miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 4, 2026

Kuwait QSR Market to Reach US$ 5,327.72 Million by 2035 Driven by Aggregator Platforms and Digital Ordering | Astute Analytica

View original at globenewswire.com
Kuwait QSR Market to Reach US$ 5,327.72 Million by 2035 Driven by Aggregator Platforms and Digital Ordering | Astute Analytica Chicago, Feb…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Analysts set target price of 3.15 AED for Americana Restaurants shares

    80% confidence
  • Corporate investment in QSR automation software increased by 22% among top-tier chains in Kuwait

    80% confidence
  • 82% of Kuwaiti consumers listed 'Halal Traceability' as their top priority when choosing a burger chain

    80% confidence
  • Fresh meat processing for the HORECA sector saw a capital influx of KWD 12 million in early 2025

    80% confidence
  • Over 60% of the regional population is under 30 years old

    80% confidence
  • In-store self-ordering kiosk usage rates climbed to 76% across renovated QSR locations

    80% confidence
  • Loyalty program members accounted for 71% of all repeat value-tier transactions in Q1

    80% confidence
  • Waste reduction protocols saved major franchise groups an estimated KWD 3.5 million annually

    80% confidence
  • Chain outlets commanded 88% of total QSR advertising spend on local social platforms in Q1 2025

    80% confidence
  • Average customer dwell time in fast-casual dining zones increased by 15 minutes per visit in 2025

    80% confidence
  • Domestic poultry production in Kuwait met 28% of local QSR demand in Q1 2025

    80% confidence
  • 'Café-style' beverage revenue within traditional burger QSRs grew by 19% year-on-year

    80% confidence
  • Keto and high-protein specific menu orders rose by 14% year-on-year across major delivery platforms

    80% confidence
  • Renovation investments focused on 'Social Seating' layouts accounted for 40% of QSR capex budgets

    80% confidence
  • The Kuwait QSR Market size was valued at USD 2,237.82 million in 2025 and is projected to hit the market valuation of USD 5,327.72 million by 2035 at a CAGR of 9.38% during the forecast period 2026–2035

    80% confidence
  • The average 'App-Exclusive' basket size is now KWD 1.850, outperforming walk-in value orders

    80% confidence
  • Consumer trust indices show chains rating 35% higher on 'Hygiene Reliability' compared to single-unit outlets

    80% confidence
  • Kuwait's QSR sector commands 45-67% of the foodservice market share, outpacing full-service outlets and cafes

    80% confidence
  • Operational costs for cloud-kitchen-based value brands dropped by 18% compared to brick-and-mortar equivalents

    80% confidence
  • Kuwait leads the GCC in food delivery, logging over 2.6 million monthly orders per capita

    80% confidence
  • Digital coupon redemption rates on aggregator apps hit a record 63% in January 2025

    80% confidence
  • Online food delivery penetration has hit 99% among Gen Z and Millennials

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Kuwait QSR Market to Reach US$ 5,327.72 Million by 2035 Driven by Aggregator Platforms and Digital Ordering | Astute Analytica — Source | Via News | es.VIA.NEWS